Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CATB | PMN | NXTC | ||
| Company | Catabasis Pharma | Promis Neurosciences Inc | Nextcure Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.21 | 0.9500 | 1.3000 | ||
| High | 9.21 | 1.0295 | 1.3000 | ||
| Low | 8.46 | 0.9500 | 1.1600 | ||
| Last | 8.54 | 1.0295 | 1.1900 | ||
| Change | -0.64 | +0.0745 | -0.1000 | ||
| % Change | -6.97% | +7.80% | -7.75% | ||
| Volume | 98,800 | 52,400 | 163,200 | ||
| 20-Day Average Volume | 395,311 | 88,590 | 44,280 | ||
| Previous Close | 9.18 | 0.9550 | 1.2900 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.72 | 1.0368 | 1.3320 | ||
| 20-Day Raw Stochastic | 56.46% | 18.11% | 6.82% | ||
| 20-Day Relative Strength | 43.24% | 47.52% | 39.92% | ||
| Weighted Alpha | -50.43 | -55.79 | -23.08 | ||
| Today's Opinion | 88% Sell | 100% Sell | 100% Sell | ||
| Previous Opinion | 72% Sell | 100% Sell | 96% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 96% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.34% since 08/31/21 | +5.05% since 11/15/24 | -9.16% since 11/15/24 | ||
| Low | 8.46 on 09/08/21 | 0.9100 on 11/20/24 | 1.1600 on 11/22/24 | ||
| High | 10.26 on 09/02/21 | 1.0400 on 11/18/24 | 1.4000 on 11/19/24 | ||
| 1-Month | |||||
| %Chg | -8.17% since 08/06/21 | +5.05% since 10/22/24 | -15.60% since 10/22/24 | ||
| Low | 6.31 on 08/20/21 | 0.9100 on 11/20/24 | 1.1600 on 11/22/24 | ||
| High | 10.26 on 09/02/21 | 1.5700 on 10/31/24 | 1.6000 on 11/12/24 | ||
| 3-Month | |||||
| %Chg | -34.10% since 06/08/21 | -17.64% since 08/22/24 | -24.68% since 08/22/24 | ||
| Low | 6.31 on 08/20/21 | 0.9100 on 11/20/24 | 1.1600 on 11/22/24 | ||
| High | 15.72 on 06/16/21 | 1.5700 on 10/31/24 | 1.6500 on 08/28/24 | ||
| 6-Month | |||||
| %Chg | -50.23% since 03/08/21 | -41.34% since 05/22/24 | -26.54% since 05/22/24 | ||
| Low | 6.31 on 08/20/21 | 0.9100 on 11/20/24 | 1.1600 on 11/22/24 | ||
| High | 22.01 on 03/18/21 | 2.3700 on 07/10/24 | 1.8199 on 07/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 33,337 | 33,653 | 33,328 | ||
| Shares Outstanding, K | 3,904 | 32,689 | 28,007 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -37,300,000 | -13,210,000 | -62,720,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -7,470,000 | 9,280,000 | -11,540,000 | ||
| 60-Month Beta | 1.66 | 0.60 | 0.80 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.14 on 11/14/24 | -0.41 on 11/07/24 | ||
| Latest Earnings Date | 08/09/21 | 11/12/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||